Literature DB >> 28641592

CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.

Ruben M W A Drost1, Ingeborg M van der Putten2, Dirk Ruwaard2, Silvia M A A Evers3, Aggie T G Paulus2.   

Abstract

OBJECTIVES: The aim of this study was to investigate how the societal perspective is conceptualized in economic evaluations and to assess how intersectoral costs and benefits (ICBs), that is, the costs and benefits pertaining to sectors outside the healthcare sector, impact their results.
METHODS: Based on a search in July 2015 using PubMed, Embase, CINAHL, and PsychINFO, a systematic literature review was performed for economic evaluations which were conducted from a societal perspective. Conceptualizations were assessed in NVivo version 11 using conventional and directed content analysis. Trial-based evaluations in the fields of musculoskeletal and mental disorders were analyzed further, focusing on the way ICBs impact the results of economic evaluations.
RESULTS: A total of 107 studies were assessed, of which 74 (69.1 percent) provided conceptualizations of the societal perspective. These varied in types of costs included and in descriptions of cost bearers. Labor productivity costs were included in seventy-two studies (67.3 percent), while only thirty-eight studies (35.5 percent) included other ICBs, most of which entailed informal care and/or social care costs. ICBs within the educational and criminal justice sectors were each included five times. Most of the trial-based evaluations analyzed further (n = 21 of 28) reported productivity costs. In nine, these took up more than 50 percent of total costs. In several studies, criminal justice and informal care costs were also important.
CONCLUSIONS: There is great variety in the way the societal perspective is conceptualized and interpreted within economic evaluations. Use of the term "societal perspective" is often related to including merely productivity costs, while other ICBs could be relevant as well.

Entities:  

Keywords:  Costs and cost analysis; Economic evaluation; Intersectoral costs and benefits; Societal perspective; Systematic literature review

Mesh:

Year:  2017        PMID: 28641592     DOI: 10.1017/S0266462317000526

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  17 in total

1.  MUW researcher of the month.

Authors:  Susanne Mayer
Journal:  Wien Klin Wochenschr       Date:  2018-11       Impact factor: 1.704

2.  Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.

Authors:  Cristina Carias; Harrell W Chesson; Scott D Grosse; Rui Li; Martin I Meltzer; Gabrielle F Miller; Louise B Murphy; Tursynbek A Nurmagambetov; Jamison J Pike; Hilary K Whitham
Journal:  Am J Prev Med       Date:  2018-01-12       Impact factor: 5.043

Review 3.  Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis.

Authors:  Alexander Konnopka; Hannah König
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

4.  The Excess Costs of Depression and the Influence of Sociodemographic and Socioeconomic Factors: Results from the German Health Interview and Examination Survey for Adults (DEGS).

Authors:  Christian Brettschneider; Alexander Konnopka; Hannah König; Alexander Rommel; Julia Thom; Christian Schmidt; Hans-Helmut König
Journal:  Pharmacoeconomics       Date:  2021-02-01       Impact factor: 4.981

Review 5.  Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice Sectors.

Authors:  Susanne Mayer; Aggie T G Paulus; Agata Łaszewska; Judit Simon; Ruben M W A Drost; Dirk Ruwaard; Silvia M A A Evers
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

6.  Value of information analysis of an early intervention for subthreshold panic disorder: Healthcare versus societal perspective.

Authors:  Robbin H Ophuis; Joran Lokkerbol; Juanita A Haagsma; Mickaël Hiligsmann; Silvia M A A Evers; Suzanne Polinder
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 7.  Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review.

Authors:  Michelle M A Kip; Gillian Currie; Deborah A Marshall; Luiza Grazziotin Lago; Marinka Twilt; Sebastiaan J Vastert; Joost F Swart; Nico Wulffraat; Rae S M Yeung; Susanne M Benseler; Maarten J IJzerman
Journal:  Pediatr Rheumatol Online J       Date:  2019-05-06       Impact factor: 3.054

8.  Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.

Authors:  Simon Walker; Susan Griffin; Miqdad Asaria; Aki Tsuchiya; Mark Sculpher
Journal:  Appl Health Econ Health Policy       Date:  2019-10       Impact factor: 2.561

9.  Future Costs in Cost-Effectiveness Analyses: Past, Present, Future.

Authors:  Linda M de Vries; Pieter H M van Baal; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

10.  Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.

Authors:  M Hiligsmann; J-Y Reginster; A N A Tosteson; S V Bukata; K G Saag; D T Gold; P Halbout; F Jiwa; E M Lewiecki; D Pinto; J D Adachi; N Al-Daghri; O Bruyère; M Chandran; C Cooper; N C Harvey; T A Einhorn; J A Kanis; D L Kendler; O D Messina; R Rizzoli; L Si; S Silverman
Journal:  Osteoporos Int       Date:  2018-10-31       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.